-
-
-
-
-
-
-
C4 Therapeutics (CCCC) Presents Monotherapy Data Demonstrating Proof of Mechanism and Early Evidence of Proof of Concept From Ongoing CFT1946 Phase 1 Trial
-
-
-
-
-
-
-
Neurocrine Biosciences (NBIX) Provides Update on ERUDITE Phase 2 Data for Luvadaxistat
-
-
-
-
-
-
-
VYNE Therapeutics (VYNE) Announces Positive Phase 1a SAD Data for VYN202
-
-
-
-
-
-
-
Aura Biosciences (AURA) Reports Positive Phase 2 End of Study Results Evaluating Bel-sar
-
-
-
-
-
-
-
iRhythm Technologies (IRTC) Announces Japanese Regulatory Approval of the Zio ECG Monitoring System, the First Product to Deliver Arrhythmia Monitoring Service Utilizing Artificial Intelligence
-
-
-
-
-
-
-
Merck (MRK) Reports Positive Top-line Results from Phase 3 Trial Evaluating Efficacy and Safety of GARDASIL 9
-
-
-
-
-
-
-
Atossa Therapeutics (ATOS) Announces Support of Final Rule from FDA Requiring Patient Notification of Breast Density, a Critical Step in Addressing a Known Risk Factor for Breast Cancer
-
68,228 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.